JJ PHARMA CONSULT ApS: Financial statements 2023
CVR: 33257635
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
JJ PHARMA CONSULT ApS (CVR 33257635) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -12,891 and a net result of DKK 17,488,303 compared with DKK 479,708 the year before. Equity in the 2023 report amounted to DKK 18,846,072. The solvency ratio was 99.4%.
- Gross Profit
- DKK -12,891
- Profit/Loss
- DKK 17,488,303
- Equity
- DKK 18,846,072
- Total Assets
- DKK 18,969,172
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -13 t. | 17.5 mio. | 18.8 mio. | - |
| 2022 | - | -19 t. | 480 t. | 2.4 mio. | 0 |
| 2021 | - | -14 t. | -593 t. | 2 mio. | - |
| 2020 | - | -20 t. | 1 mio. | 2.7 mio. | - |
| 2019 | - | -22 t. | -27 t. | 1.8 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
JJ PHARMA CONSULT ApS has published its annual report for 2022. Gross profit came to DKK -19,376, and the net result was DKK 479,708.
About JJ PHARMA CONSULT ApS
JJ PHARMA CONSULT ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2010. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Jack Groth Jacobsen. The company is owned by Jack Groth Jacobsen. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -79,088 and a net result of DKK -1,189,064 compared with DKK 1,260,145 the year before. Equity in the 2025 report amounted to DKK 16,917,153.